XORTX Therapeutics Inc (XRTX) Stock Price, Quote, News & History

XRTXNASDAQ
$2.33
0.2210.43%
Last update: Sep 11, 7:59 PM
$2.05
-0.06-2.84%

XORTX Therapeutics (XRTX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.10M
Investing Cash Flow (TTM)
-417.12K
Financing Cash Flow (TTM)
5.46M
Free Cash Flow (TTM)
-5.28M
Capital Expenditure (TTM)
-177.39K
Net Change in Cash (TTM)
-61.10K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$3.60M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.70
Earnings Yield % (TTM)
-122.27%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.03

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$80.47K
Total Cash
$994.05K
Debt to Equity
0.00
Issuance of Debt (TTM)
-$80.47K
Repayment of Debt (TTM)
-$80.47K

Key Statistics

Open
$2.41
Close
$2.33
Volume / Avg.
1.92M / 36.36K
Day Range
$2.17 - $2.45
52 Wk Range
1.73 - 35.25
Market Cap
$3.72M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
0.82%
Days to Cover
1.3

About

Sector
Health Care
Industry
Pharmaceuticals
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-int...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy XORTX Therapeutics (XRTX) stock?

A

You can purchase shares of XORTX Therapeutics (NASDAQ:XRTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are XORTX Therapeutics (XRTX) competitors?

Q

What is the forecast, or price target, for XORTX Therapeutics (XRTX) stock?

A

XORTX Therapeutics has a consensus price target of $70.00.

Q

What is the current price for XORTX Therapeutics (XRTX)?

A

The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $2.05 last updated September 11, 2026 at 7:59 PM EDT.

Q

Does XORTX Therapeutics (XRTX) pay a dividend?

A

There are no upcoming dividends for XORTX Therapeutics.

Q

When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?

A

XORTX Therapeutics does not have any upcoming earnings scheduled.

Q

Is XORTX Therapeutics (XRTX) going to split?

A

There is no upcoming split for XORTX Therapeutics.

Q

What sector and industry does XORTX Therapeutics (XRTX) operate in?

A

XORTX Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.